International Clinical Trial: HZALS Cohort--Construction and Characterization Study of a Clinical Cohort for Amyotrophic Lateral Sclerosis

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131397) titled 'HZALS Cohort--Construction and Characterization Study of a Clinical Cohort for Amyotrophic Lateral Sclerosis' on Sept. 1.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Hangzhou First People's Hospital

Condition: amyotrophic lateral sclerosis

Intervention: PD Group:None AD Group:None ALS Group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-01

Target Sample Size: PD Group:60;AD Group:100;ALS Group:600;Healthy Control group:200;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=335149...